Clinical Trials Logo

Head and Neck Neoplasms clinical trials

View clinical trials related to Head and Neck Neoplasms.

Filter by:

NCT ID: NCT04598087 Recruiting - Surgery Clinical Trials

Prehabilitation and Recovery After Head and Neck Cancer Surgery

Start date: February 9, 2022
Phase: N/A
Study type: Interventional

Implementing a multiphasic, multimodal prehabilitation intervention for people undergoing surgery with free flap reconstruction for the treatment of head and neck cancer.

NCT ID: NCT04597177 Active, not recruiting - Clinical trials for Swallowing Dysfunction

SW-IMRT Versus ST-IMRT in the Treatment of Head and Neck Cancer

Start date: September 1, 2015
Phase: N/A
Study type: Interventional

To clinically validate whether SW-IMRT actually reduce the occurrence of swallowing dysfunction as compared to ST-IMRT.

NCT ID: NCT04595981 Not yet recruiting - Clinical trials for Squamous Cell Carcinoma

Chemo-embolization for Head and Neck Cancer

Start date: May 2025
Phase: Phase 2
Study type: Interventional

The study will evaluate whether adjuvant chemo-embolization increases progression free and/or overall survival relative to standard of care radiation and chemo- and/or immunotherapy in cisplatin-ineligible head and neck cancer patients with an acceptable morbidity rate.

NCT ID: NCT04593914 Withdrawn - Clinical trials for Head and Neck Cancer

A Novel Skin Barrier Protectant for Acute Radiodermatitis

CASP-ORL
Start date: September 1, 2020
Phase: N/A
Study type: Interventional

Acute radiodermatitis (ARD) is a distressing and painful skin reaction that occurs in 95% of the patients undergoing radiotherapy (RT). To date, there is still no general approved guideline for the prevention and management of acute radiodermatitis. The 3M™ Cavilon™ Advanced Skin Protectant is a novel skin barrier protectant that acts as a physical barrier against abrasion, moisture, and irritants. Moreover, it enables an environment for wound healing. The aim of this study is to evaluate the effectiveness of 3M™ Cavilon™ Advanced Skin Protectant in the prevention and management of ARD in patients with head and neck cancer.

NCT ID: NCT04593589 Recruiting - Clinical trials for Head and Neck Cancer

Submandibular Gland Stem Cell Transplantation

RESTART
Start date: May 10, 2022
Phase: Phase 1
Study type: Interventional

This study is a phase I safety and feasibility study to treat head and neck cancer patients with autologous salivary gland stem cell transplantation after postoperative (chemo)radiotherapy.

NCT ID: NCT04566367 Active, not recruiting - Esophageal Cancer Clinical Trials

Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer

Start date: September 22, 2020
Phase: N/A
Study type: Interventional

This study wants to focus on Carcinoma detection rates with blue laser imaging (BLI) for participants with head-neck cancer who need a percutaneous endoscopic gastrostomy (PEG). BLI is a new imaging technique that can easily be used within a standard gastroscopy.

NCT ID: NCT04565457 Recruiting - Prostate Cancer Clinical Trials

A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality

Start date: April 21, 2023
Phase: N/A
Study type: Interventional

This is Pilot study that investigates the CBCT(Cone beam computed tomography) image quality improvement provided by the 2D antiscatter grid technology. The primary objective is to assess the improvement in tissue visualization in an observer study, which will be conducted in a blinded fashion.

NCT ID: NCT04554667 Completed - Clinical trials for Cancer of Head and Neck

Heavy Lifting Strength Training in Head and Neck Cancer Survivors

LIFTING
Start date: November 24, 2020
Phase: Phase 1
Study type: Interventional

The LIFTING trial will examine the feasibility and safety of a heavy lifting strength training (HLST) program in head and neck cancer survivors (HNCS) at least 1 years post surgical neck dissection. The trial will determine whether this training style is safe and feasible in HNCS. Physical and psychosocial changes will also be reported.

NCT ID: NCT04552587 Completed - Clinical trials for Head and Neck Cancer

The HEART Study (Healthy Eating and Recovery Together)

Start date: December 4, 2020
Phase: N/A
Study type: Interventional

Head and neck cancer survivors and their primary caregivers (N=25 dyads) will be enrolled to pilot test a nutrition support system with a care planning clinic visit and a caregiver mobile App. Participants will be asked to complete baseline and 6-week follow-up surveys. The clinic session (offered in person or remotely) will include a needs assessment and a tailored care plan with information, educational materials and referrals about participants' symptoms, behaviors, social concerns and caregiving tasks. After the visit, the program will provide an App for caregivers with follow-up resources and mobile support for one month.

NCT ID: NCT04545957 Recruiting - Prostate Cancer Clinical Trials

Jump: MR Simulation For Radiation Therapy Master Protocol

JUMP
Start date: October 14, 2020
Phase: N/A
Study type: Interventional

This is a master protocol for a prospective Phase I-II study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of radiation treatments.